Pioglitazone hydrochloride

Cat. No.: 0225LY-0861

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR, and LC-MS.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: Pioglitazone hydrochloride is a thiazolidinedione-class hydrochloride salt that is orally bioavailable and exhibits antidiabetic activity along with potential antineoplastic characteristics.

Synonym: U-72107E; AD 4833; U 72107A; Pioglitazone HCl; 112529-15-4; Piomed; 5-(4-(2-(5-Ethylpyridin-2-yl)ethoxy)benzyl)thiazolidine-2,4-dione hydrochloride; Pioglitazone (hydrochloride); U-72107A; MFCD04975446; Pioglitazone (as hydrochloride); Pioglitazonehydrochloride; 5-[4-[2-(5-ethyl-2-pyridyl)ethoxy]benzyl]thiazolidine-2,4-dione hydrochloride; [5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-] thiazolidinedione hydrochloride; NSC 758876; Pioditazone hydrochloride; 5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione monohydrochloride; (+-)-5-(p-(2-(5-Ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione monohydrochloride; 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione;hydrochloride

CAS No.: 112529-15-4

Compound CID: 60560

Formula: C₁₉H₂₀N₂O₃S·HCl

Formula Weight: 392.9

Specification

Targets&IC50: PPARγ (human): 0.93 μM (EC50); PPARγ (mouse): 0.99 μM (EC50)

Relative Density: 1.26 g/cm³

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: Pioglitazone hydrochloride can be used in diabetes research to study the regulation of gene expression involved in glucose and lipid metabolism.